Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Ophthalmology Reports|October 21, 2014
Regenerative Cell Therapy for Corneal EndotheliumAlena Bartakova, Noelia J Kunzevitzky, Jeffrey L GoldbergJournal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|August 18, 2017
CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinomaAlena Bartakova, Kveta Michalova, Jiri Presl, et al.Investigative Ophthalmology & Visual Science|April 7, 2018
A Cell Culture Approach to Optimized Human Corneal Endothelial Cell FunctionAlena Bartakova, Olga Kuzmenko, Karen Alvarez-Delfin, et al.The Journal of Biological Chemistry|May 3, 2014
The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growthJacqueline Sayyah, Alena Bartakova, Nekeisha Nogal, et al.Investigative Ophthalmology & Visual Science|May 20, 2016
Novel Identity and Functional Markers for Human Corneal Endothelial CellsAlena Bartakova, Karen Alvarez-Delfin, Alejandra D Weisman, et al.Cancer Medicine|January 24, 2019
Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analysesKarolina Seborova, Radka Vaclavikova, Pavel Soucek, et al.Journal of Cancer|November 21, 2017
Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal MetastasisKaterina Elsnerova, Alena Bartakova, Josef Tihlarik, et al.International Journal of Molecular Sciences|October 16, 2024
Microfluidic Affinity Selection of B-Lineage Cells from Peripheral Blood for Minimal Residual Disease Monitoring in Pediatric B-Type Acute Lymphoblastic Leukemia PatientsMalgorzata A Witek, Nicholas E Larkey, Alena Bartakova, et al.Plos One|May 15, 2015
Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low NeuroblastomaShanique A Young, Katelyn E McCabe, Alena Bartakova, et al.Oncotarget|September 30, 2015
A strategy to combine pathway-targeted low toxicity drugs in ovarian cancerJoe R Delaney, Chandni Patel, Katelyn E McCabe, et al.Pageof 2